Drugmaker Novo Nordisk bets $145 mln on post-Brexit UK science

LONDON, Jan 30 (Reuters) - Novo Nordisk, the world's top maker of diabetes drugs, is investing 115 million pounds ($145 million) in a new research centre in Britain, undeterred by Brexit. [Source]

Origin: reuters.com

Category: rbssHealthcareNews

Topics: Nordisk, Brexit, undeterred, Britain, centre, research, million), ($145, million pounds, investing, drugs, diabetes, maker, the world's, (Reuters), LONDON, science, post-Brexit, Drugmaker

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/zWMZzQULxow/novo-nordisk-britain-idUSL5N1FG5CD